ArticleDiabetology & metabolic syndrome2026
Agomelatine and the potential inverse risk of metabolic disorders: a nationwide cohort study with an active comparator design in Taiwan.
Yuan-Liang Wen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.